Literature DB >> 34580064

Histone H1 Mutations in Lymphoma: A Link(er) between Chromatin Organization, Developmental Reprogramming, and Cancer.

Alexey A Soshnev1, C David Allis2, Ethel Cesarman3, Ari M Melnick4.   

Abstract

Aberrant cell fate decisions due to transcriptional misregulation are central to malignant transformation. Histones are the major constituents of chromatin, and mutations in histone-encoding genes are increasingly recognized as drivers of oncogenic transformation. Mutations in linker histone H1 genes were recently identified as drivers of peripheral lymphoid malignancy. Loss of H1 in germinal center B cells results in widespread chromatin decompaction, redistribution of core histone modifications, and reactivation of stem cell-specific transcriptional programs. This review explores how linker histones and mutations therein regulate chromatin structure, highlighting reciprocal relationships between epigenetic circuits, and discusses the emerging role of aberrant three-dimensional chromatin architecture in malignancy. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34580064      PMCID: PMC8678342          DOI: 10.1158/0008-5472.CAN-21-2619

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  147 in total

1.  Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation.

Authors:  Yuhong Fan; Tatiana Nikitina; Jie Zhao; Tomara J Fleury; Riddhi Bhattacharyya; Eric E Bouhassira; Arnold Stein; Christopher L Woodcock; Arthur I Skoultchi
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

2.  Histone modification: cause or cog?

Authors:  Steven Henikoff; Ali Shilatifard
Journal:  Trends Genet       Date:  2011-07-20       Impact factor: 11.639

3.  A Robust Method for the Purification and Characterization of Recombinant Human Histone H1 Variants.

Authors:  Adewola Osunsade; Nicholas A Prescott; Jakob M Hebert; Devin M Ray; Yazen Jmeian; Ivo C Lorenz; Yael David
Journal:  Biochemistry       Date:  2019-01-08       Impact factor: 3.162

4.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.

Authors:  Wendy Béguelin; Relja Popovic; Matt Teater; Yanwen Jiang; Karen L Bunting; Monica Rosen; Hao Shen; Shao Ning Yang; Ling Wang; Teresa Ezponda; Eva Martinez-Garcia; Haikuo Zhang; Yupeng Zheng; Sharad K Verma; Michael T McCabe; Heidi M Ott; Glenn S Van Aller; Ryan G Kruger; Yan Liu; Charles F McHugh; David W Scott; Young Rock Chung; Neil Kelleher; Rita Shaknovich; Caretha L Creasy; Randy D Gascoyne; Kwok-Kin Wong; Leandro Cerchietti; Ross L Levine; Omar Abdel-Wahab; Jonathan D Licht; Olivier Elemento; Ari M Melnick
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

5.  Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.

Authors:  Bjoern Chapuy; Chip Stewart; Andrew J Dunford; Jaegil Kim; Atanas Kamburov; Robert A Redd; Mike S Lawrence; Margaretha G M Roemer; Amy J Li; Marita Ziepert; Annette M Staiger; Jeremiah A Wala; Matthew D Ducar; Ignaty Leshchiner; Ester Rheinbay; Amaro Taylor-Weiner; Caroline A Coughlin; Julian M Hess; Chandra S Pedamallu; Dimitri Livitz; Daniel Rosebrock; Mara Rosenberg; Adam A Tracy; Heike Horn; Paul van Hummelen; Andrew L Feldman; Brian K Link; Anne J Novak; James R Cerhan; Thomas M Habermann; Reiner Siebert; Andreas Rosenwald; Aaron R Thorner; Matthew L Meyerson; Todd R Golub; Rameen Beroukhim; Gerald G Wulf; German Ott; Scott J Rodig; Stefano Monti; Donna S Neuberg; Markus Loeffler; Michael Pfreundschuh; Lorenz Trümper; Gad Getz; Margaret A Shipp
Journal:  Nat Med       Date:  2018-04-30       Impact factor: 53.440

6.  HP1 proteins compact DNA into mechanically and positionally stable phase separated domains.

Authors:  Madeline M Keenen; David Brown; Lucy D Brennan; Roman Renger; Harrison Khoo; Christopher R Carlson; Bo Huang; Stephan W Grill; Geeta J Narlikar; Sy Redding
Journal:  Elife       Date:  2021-03-04       Impact factor: 8.140

7.  Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage.

Authors:  Chi-Shuen Chu; Johannes C Hellmuth; Rajat Singh; Hsia-Yuan Ying; Lucy Skrabanek; Matthew R Teater; Ashley S Doane; Olivier Elemento; Ari M Melnick; Robert G Roeder
Journal:  Mol Cell       Date:  2020-11-23       Impact factor: 19.328

8.  Cancer-associated mutations of histones H2B, H3.1 and H2A.Z.1 affect the structure and stability of the nucleosome.

Authors:  Yasuhiro Arimura; Masae Ikura; Risa Fujita; Mamiko Noda; Wataru Kobayashi; Naoki Horikoshi; Jiying Sun; Lin Shi; Masayuki Kusakabe; Masahiko Harata; Yasuyuki Ohkawa; Satoshi Tashiro; Hiroshi Kimura; Tsuyoshi Ikura; Hitoshi Kurumizaka
Journal:  Nucleic Acids Res       Date:  2018-11-02       Impact factor: 16.971

9.  The H3K36me2 writer-reader dependency in H3K27M-DIPG.

Authors:  Jia-Ray Yu; Gary LeRoy; Devin Bready; Joshua D Frenster; Ricardo Saldaña-Meyer; Ying Jin; Nicolas Descostes; James M Stafford; Dimitris G Placantonakis; Danny Reinberg
Journal:  Sci Adv       Date:  2021-07-14       Impact factor: 14.957

10.  Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.

Authors:  Man Chun John Ma; Saber Tadros; Alyssa Bouska; Tayla Heavican; Haopeng Yang; Qing Deng; Dalia Moore; Ariz Akhter; Keenan Hartert; Neeraj Jain; Jordan Showell; Sreejoyee Ghosh; Lesley Street; Marta Davidson; Christopher Carey; Joshua Tobin; Deepak Perumal; Julie M Vose; Matthew A Lunning; Aliyah R Sohani; Benjamin J Chen; Shannon Buckley; Loretta J Nastoupil; R Eric Davis; Jason R Westin; Nathan H Fowler; Samir Parekh; Maher Gandhi; Sattva Neelapu; Douglas Stewart; Kapil Bhalla; Javeed Iqbal; Timothy Greiner; Scott J Rodig; Adnan Mansoor; Michael R Green
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

View more
  1 in total

1.  Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma.

Authors:  Wuping Yang; Jingcheng Zhou; Zedan Zhang; Kenan Zhang; Yawei Xu; Lei Li; Lin Cai; Yanqing Gong; Kan Gong
Journal:  Int J Biol Sci       Date:  2022-03-21       Impact factor: 6.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.